12-Year-Olds Could Get Mpox Vaccine in EU if Approved

Bavarian Nordic today said it plans to seek European regulatory approval for its mpox vaccine…

Children's Health Defense

Mpox vaccine maker Bavarian Nordic today said it plans to seek European regulatory approval for its vaccine for children ages 12-17 after the World Health Organization (WHO) on Wednesday declared a global public health emergency.

The U.S. Food and Drug Administration granted the vaccine an “emergency use authorization” for adolescents during the 2022 global mpox outbreak, according to Medical Xpress.

Meanwhile, medical commentator John Campbell, Ph.D., said today on his YouTube show that — based on evidence from the WHO, the Centers for Disease Control and Prevention (CDC), and U.K. government official data sources — he believes the probability of “ongoing sustained transmission” of mpox in the West is “remarkably low.”

In May 2022, the WHO announced it would phase out the name “monkeypox” and rename the disease “mpox” to avoid the stigma generated by associating the disease with monkeys.

Mpox typically not transmitted by air

Campbell reviewed official information about mpox, such as how the disease is transmitted and its symptomatic stages.

He said there are two types of mpox: clade 1 and clade 2. Both are typically transmitted via close contact or sexual contact, according to the CDC. Examples include skin-to-skin, mouth-to-mouth, mouth-to-skin contact and sex. It can also be spread by touching objects recently touched by a person with the disease, such as towels or sheets…